Evidence map›Paper›PMID 26500084›Full record

ArticlePreventive medicine2015

Cervical cancer screening among women ≥70 years of age in the United States-A referral problem or patient choice.

Fangjian Guo, Jacqueline M Hirth, Abbey B Berenson

Abstract read
In one paragraph

Article in Preventive medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fangjian GuoDepartment of Obstetrics & Gynecology, and Center for Interdisciplinary Research in Women's Health, The University of Texas Medical Branch, Galveston, TX, United States.
Jacqueline M HirthDepartment of Obstetrics & Gynecology, and Center for Interdisciplinary Research in Women's Health, The University of Texas Medical Branch, Galveston, TX, United States.
Abbey B BerensonDepartment of Obstetrics & Gynecology, and Center for Interdisciplinary Research in Women's Health, The University of Texas Medical Branch, Galveston, TX, United States. Electronic address: abberens@utmb.edu.

Funding

UTMB WOMEN'S HEALTH RESEARCH SCHOLARS PROGRAMK12HD052023 · NICHD · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI BERENSON, ABBEY B · 2005 to 2023
$8.1M
Interdisciplinary Women's Reproductive Health Fellowship (RHF)T32HD055163 · NICHD · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BERENSON, ABBEY B · 2008 to 2017
$1.7M
NICHD NIH HHS K12 HD052023NICHD NIH HHS T32 HD055163
6 · The paper itself

Abstract

objectiveClinical guidelines recommend that women with a history of adequate screening and not otherwise at high risk may discontinue cervical cancer screening after 65 years of age. However, screening remains common among US women over 65 years old. This study was conducted to examine whether overutilization was attributable to provider's recommendation or patient choice.

methodThis cross-sectional study used data from 1752 female participants (70+ years) from the 2013 National Health Interview Survey (NHIS). We quantitatively assessed the proportions of provider-recommended and patient self-initiated Pap smears.

resultsAmong female respondents, 40.8% had a Pap smear within the past 3 years, 19.4% had a Pap smear in the last year, and 39.7% reported receiving a recommendation for a Pap smear from their provider in the past year. Among women who received a recommendation to obtain a Pap smear, 39.8% did so within the past 12 months compared to 5.9% of women who did not receive a recommendation (adjusted odds ratio 10.5, 95% confidence interval 7.39-15.0). About 70% of women who visited an obstetrician/gynecologist and reported receiving a recommendation to have a Pap smear did so in the past year, while 32.3% of women who visited an obstetrician/gynecologist but did not receive a recommendation obtained one.

conclusionPap smears were common among women ≥70 years of age. Health care providers may need additional education on current guidelines regarding indications for Pap smears in this age group to help reduce screening of patients who may not benefit.

Indexed as

Choice BehaviorMass ScreeningAgedCross-Sectional StudiesEarly Detection of CancerFemaleHealth SurveysHumansPapanicolaou TestPatient Acceptance of Health CareReferral and ConsultationSocioeconomic FactorsUnited StatesUterine Cervical NeoplasmsCancer screeningCervical cancerOverutilization of health servicesPap smear

Identifiers

PMID26500084
PMCPMC4679483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.